Drug Type Antibody-photosensitizer conjugates, Liposomal Drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ovarian Cancer | Preclinical | United States | 28 Apr 2025 | |
| Ovarian Cancer | Preclinical | Finland | 28 Apr 2025 | |
| Peritoneal Neoplasms | Preclinical | United States | 28 Apr 2025 | |
| Peritoneal Neoplasms | Preclinical | Finland | 28 Apr 2025 |





